Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,092,134
+$564,267 QoQ
Shares Held
8,314
+18.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#1,926
of 4,153 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 15%
Shared 0%
None 85%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hexagon Capital Partners LLC holds $11,707,728 across 11 Drug Manufacturers - General names. ABBV ranks #1 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
8,314 | $2,092,134 | |
| 2 | MRK |
Merck & Co., Inc.
|
13,420 | $1,724,470 | |
| 3 | LLY |
ELI LILLY & Co
|
1,184 | $1,420,125 | |
| 4 | PFE |
Pfizer Inc
|
54,852 | $1,320,836 | |
| 5 | JNJ |
Johnson & Johnson
|
5,167 | $1,312,262 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
18,323 | $1,055,771 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,901 | $871,872 | |
| 8 | NVS |
Novartis AG
|
3,990 | $625,312 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,092,134 | 8,314 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,527,867 | 7,025 | Shares | Sole | 2026-05-05 | |
| 2025-03-31 | $1,603,037 | 7,651 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,417,157 | 7,975 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,465,696 | 7,422 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $1,343,173 | 7,831 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,525,998 | 8,380 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $1,200,087 | 7,744 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,211,857 | 8,130 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $963,184 | 7,149 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $1,248,026 | 7,831 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,144,845 | 7,084 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,052,072 | 7,839 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $601,612 | 3,928 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $550,687 | 3,397 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $492,179 | 3,635 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $394,264 | 3,655 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $353,914 | 3,142 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $339,053 | 3,133 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $325,521 | 3,038 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $248,492 | 2,837 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||